Cardiac Arrhythmias 2005

Supraventricular Arrhythmia and Atrial Flutter: Inappropriate sinus tachycardia: which mechanism, diagnosis and treatment?.-Right and left atrial flutter: how to differentiate them on the basis of surface electocardiogram?.-Atypical atrial flutter: how to diagnose, locate and ablate it?.-Catheter ablation of typical atrial flutter: which long-term results and predictors of recurrences?.-Atrial fibrillation ablation of typical atrial flutter: who is at risk?.-Electroanatomical mapping to support ablation of complex supraventricular arrhythmias: does it matter?.-Atrial Fibrillation: Pathophysiology, Clinical and Therapeutical Aspects: Idiopathic atrial fibrillation: which electrophysiological substrate?.-Inflammation and infection: an underestimated cause of atrial fibrillation?.-Atrial remodelling 10 years later: what have we learned?.-Atrial fibrillation and heart failure: is one epidemic feeding the other and how to interrupt the vicious circle?.-Atrial fibrillation: what is the impact of the different therapies on quality of life?.-Pill in the pocket approach for outpatient treatment of recent-onset atrial fibrillation: the obvious solution?.-Pharmacological cardioversion of atrial fibrillation: which drugs to prefer, class I C or class III?.-Early recurrences of atrial fibrillation: how to predict and prevent them?.-When to attempt cardioversion of atrial fibrillation in the era of AFFIRM and RACE? The exception.-Dronedarone for prevention of atrial fibrillation: an unfulfilled promise?.-Management of AF in patients with no structural heart disease.-Primary prevention of Atrial Fibrillation in hypertensive patients: which news from LIFE trial?.-Prognosis and Management of Atrial Fibrillation in Patients with Acute Myocardial Infarction.-Post-CABG atrial fibrillation: which incidence, predictors, treatment and long-term outcome?.-Post PCI atrial fibrillation: which clinical and prognostic significance?.-Perioperative interruption of warfarin: how effective and safe is bridging therapy with low- molecular weight heparin ?.-How safe is anticoagulant therapy in older patients and what should be the INR target?.-Oral antithrombin agents: will they replace warfarin?.-Guidelines for anticoagulation of atrial fibrillation: is it time for an update?.-Atrial Fibrillation: Catheter Ablation and Other Non-Pharmacological Therapies: Anatomy of left atrium and pulmonary veins: what have we learned in the last years?.-Imaging in arrhythmic syndromes: what is the role of cardiac radiology?.-Value of transoesophageal ecocardiography for the ablation of AF.-Value of the LOCALISA Non Fluoroscopic Mapping System to guide the ablation of AF.-Linear atrial lesions should be always performed in addition to circumferential pulmonary vein isolation.-Systematic electrical disconnection of superior vein cava in addition to pulmonary vein ablation: is it worthwhile?.-What is the outcome of atrial fibrillation ablation in patients with LV dysfunction?.-Complications of atrial fibrillation ablation: how to prevent and manage cerebrovascular accidents.-Complications of AF ablation: how to prevent and manage pulmonary vein stenosis.-Atrial fibrillation ablation should be considered a first-line therapy.-Long-term use of atrial and dual defibrillator: what have we learned?.-Hybrid therapy as an alternative in refractory atrial fibrillation: when, why and how?.-Ablate and pace: which role today?.-Ereditary Arrhythmogenic Syndromes: Fever and other precipitants of ventricular arrhythmias in Brugada syndrome: do we know how they act?.-Drug challenge in Brugada syndrome: how valuable is it?.-Electrophysiologic study in Brugada syndrome: more questions than answers?.-Short QT syndrome: how frequent is it and what are the peculiar features?.-ICD therapy for short QT syndrome: what is the risk of inappropriate shocks and how to avoid it?.-Quinidine to treat short QT syndrome: a real alternative to ICD?.-ICD for long QT syndrome: which indications, complications and results?.-How to differentiate right ventricular outflow tract tachycardia from arrhythmogenic right ventricular cardiomiopathy?.-How to diagnose and ablate idiopathic ventricular tachycardia originating from the aortic sinus cusp?.-How to diagnose and approach epicardial ventricular tachycardia?.-Sudden Death: Prediction and Prevention: Predicting Sudden Death in Athletes.-Newer Markers of Sudden Death: Genetic variables.-Sudden arrhythmic death: which genetic determinants?.-Brain natriuretic peptide: will it improve risk stratification of sd?.-Non esterified fatty acids as markers of SD.-Value of angiotensin-converting enzyme inhibitors to prevent SD.-Value of aldosterone receptor blockers to prevent SD.-After DEFINITE / SCD HeFT / COMPANION: do we need to implant an ICD in all patients with heart failure?.-Health care system: the dilemma between clinical needs and limited resources. How to answer it?.-Cost-effectiveness and aspects of health economics in primary prevention: what is the case of dilated cardiomyopathy?.-Public access defibrillation: how diffuse is it and what are the short and long-term results?.-In-hospital cardiac arrest: how to improve survival?.-Cardiac Resinchronisation Therapy: Indications and Results: Value of conventional transthoracic ecocardiography in candidates to CRT.-Three-dimensional echocardiography: which role for CRT patients?.-Upgrading from right ventricular to biventricular pacing: when, why and how?.-CRT: how to identify patients who will not respond to therapy?.-Value of CRT in patients with atrial fibrillation.-Indications to CRT with NYHA class I - II.-CRT: is it antiarrhythmic or proarrhythmic?.-Impact of CRT on mortality: which preliminary results from CARE-HF trial?.-CRT: what is the long-term retention?.-Cardiac Pacing: Technical and Clinical Aspects: Right ventricular pacing: is it really that bad?.-How important is to preserve spontaneous AV conduction in patients with DDD pacemaker and sick sinus syndrome?.-Drug-induced bradycardia: to pace or not to pace?.-Sleep-apnea syndrome: CPAP or cardiac pacing?.-Rate-responsive pacing controlled by the TVI sensor in the treatment of sick sinus syndrome.-Preliminary test of a new hemodynamic pacemaker. Evaluation of sensor safety..-From analogue to digital technology: what are the clinical benefits?.-What are the benefits of morphological signal analysis?.-How can new technologies help to make follow-up easier?.-Can patients with implantated pacemakers / ICD undergo magnetic resonance imaging?.-Interference of cellular phones and metal detectors with pacemakers and ICD: still a problem?.-Syncope: Evaluation and Therapies:Syncope in children and adolescents: what are the peculiar features?.-Syncope in patients with autonomic nervous system disturbances: which diagnosis and treatment?.-Syncope unit: how to better organize it? The North American experience.-Syncope unit: how to better organize it? The European experience.-Water ingestion as prophylaxis against syncope: fact or fancy?.-Counter-pressure manoeuvres to abort impeding syncope: are they really useful?.-Compression stockings to combat vasovagal syncope: which rationale?.-Betablockers for prevention of vasovagal syncope: who may benefit from the treatment?.-Has psychiatric treatment any role in the management of vasovagal syncope?.-Familial vasovagal syncope: which genetic substrate and clinical characteristics?